Golden House Ltd (TLV:GOHO)
992.90
-60.10 (-5.71%)
May 15, 2026, 1:44 PM IDT
Golden House Market Cap
Golden House has a market cap or net worth of 154.06 million as of May 15, 2026. Its market cap has decreased by -29.53% in one year.
Market Cap
154.06M
Enterprise Value
122.34M
Revenue
46.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
992.90
Market Cap Chart
Since March 30, 2006, Golden House's market cap has increased from 74.77M to 154.06M, an increase of 106.05%. That is a compound annual growth rate of 3.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 154.06M | -2.85% |
| Dec 31, 2025 | 158.58M | -55.97% |
| Dec 31, 2024 | 360.14M | 47.35% |
| Dec 31, 2023 | 244.41M | 50.96% |
| Dec 29, 2022 | 161.90M | -36.51% |
| Dec 30, 2021 | 255.00M | 16.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 119.33B |
| Danel (Adir Yeoshua) | 2.62B |
| Amal Holdings A.D. | 2.37B |
| BrainsWay | 1.85B |
| Geffen Residence & Renewal | 334.87M |
| Epitomee Medical | 221.29M |
| InterCure | 132.60M |
| Rekah Pharmaceutical Industry | 126.02M |